This inventor holds 1 USPTO granted patent. Top assignee: Turun Yliopisto. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Eleonora Mäkelä: Innovator in Cancer Biomarkers
Introduction
Eleonora Mäkelä is a prominent inventor based in Turku, Finland. She has made significant contributions to the field of cancer research through her innovative work on biomarkers. Her dedication to advancing medical science is evident in her patented inventions.
Latest Patents
Mäkelä holds a patent for a novel cancer-associated biomarker known as the CIP2A variant. This invention, denoted as NOCIVA, includes various applications and uses. It encompasses a splice variant of CIP2A, along with binding bodies such as probes, amplification primers, and antibodies specific to this variant. The patent also outlines methods for detecting and prognosing cancer based on the splice variant, as well as a kit designed for use in these methods. She has 1 patent to her name.
Career Highlights
Eleonora Mäkelä is affiliated with Turun Yliopisto, where she continues her research and development in the field of cancer biomarkers. Her work has garnered attention for its potential impact on cancer detection and treatment.
Collaborations
Mäkelä collaborates with Jukka Westermarck, a fellow researcher in the field. Their partnership enhances the research efforts aimed at improving cancer diagnostics and therapeutics.
Conclusion
Eleonora Mäkelä's contributions to cancer research through her innovative patent highlight her role as a key figure in the scientific community. Her work promises to advance the understanding and treatment of cancer, making a significant impact on healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile